Cambodia vs France: Antiretroviral therapy coverage
Cambodia
92.0%
in 2024
France
91.0%
in 2022
Cambodia rank
14th
France rank
17th
Antiretroviral therapy coverage over time
- Cambodia
- France
How they compare
Cambodia currently reports 92.0% against 91.0% in France, a difference of 1.0%.
Across all 23 years both countries report, France has been ahead every year.
Cambodia ranks 14th and France ranks 17th of 143 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.6% | 79.9% | 64.3% | France |
| 2010s | 64.6% | 88.0% | 23.4% | France |
| 2020s | 82.0% | 90.0% | 8.0% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Cambodia or France?
- Cambodia, at 92.0% against 91.0% in France as of 2024.
- What is the difference in antiretroviral therapy coverage between Cambodia and France?
- 1.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and France?
- 23 years are reported by both, from 2000 to 2022.
- How do Cambodia and France rank globally for antiretroviral therapy coverage?
- Cambodia ranks 14th and France ranks 17th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.